PRELIM 02 - Concepts in Pharmaceutical Quality Assurance Flashcards

1
Q

Refers to the action of proving that any procedure, process, equipment, material, activity, or system actually and consistently leads to the expected results

A

Validation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

This team’s responsibility is to identify needs, develop protocols, and conduct validation/qualification

A

Validation team

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Is a high-level document that establishes an umbrella validation plan for the entire product

A

Validation master plan (VMP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Refers to the process of establishing documented evidence that a process used in manufacture does what it purports to do

A

Prospective validation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Refers to validation carried during routine production of products intended for sale

A

Concurrent validation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Refers to validation of a process for a product that has been marketed based upon accumulated manufacturing

A

Retrospective validation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Refers to repeated validation of an approved process to ensure continued compliance with established requirements

A

Revalidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Refers to the action of proving and documenting that premises, systems, and equipment are properly installed

A

Qualification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Validation that demonstrates that an analytical procedure is suitable for its intended purpose

A

Analytical method validation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The ability to assess unequivocally the analyte in the presence of components which may be expected to be present

A

Specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The ability to obtain test results which are directly proportional to the concentration of analyte in the sample

A

Linearity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The interval between the upper and lower concentration of analyte in the sample

A

Range

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Expresses the closeness of agreement between the value which is accepted either as a conventional true value or an accepted reference value

A

Accuracy/Trueness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Expresses the closeness of agreement between a series of measurements obtained from multiple sampling of the same homogenous sample

A

Precision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Expresses the precision under the same operating conditions over a short interval of time

A

Repeatability/Intra-assay precision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Expresses within-laboratories variations: different days, different analysts, different equipment, etc.

A

Intermediate precision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Expresses the precision between laboratories (collaborative studies, usually applied to standardization of methodology)

A

Reproducibility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

A limit that refers to the lowest amount of analyte in a sample which can be detected but not necessarily quantitated as an exact value

A

Detection limit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

A measure of the capacity to remain unaffected by small, but deliberate variations in method parameters

A

Robustness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Type of testing based on the concept that the equipment, electronics, analytical operations and samples to be analyzed constitute an integral system that can be evaluated as such

A

System suitability testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Refers to the actions taken to remove a product from the market

A

Product recall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

An NSAID and a prescription painkiller that was recalled in 2004 due to risk of deadly heart attacks

A

Rofecoxib (Vioxx)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

An alert issued within 24 hours after the FDA director general approves a product recall order

A

Public health alert

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Situation in which there is a reasonable probability that the use or exposure to the product will cause serious adverse health consequences or death (Recall classification)

A

Class 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Situation in which use or exposure to the product may cause temporary or medically reversible adverse health consequences (Recall classification)
Class 2
26
Situation in which use or exposure to the product is not likely to cause adverse health consequences (Recall classification)
Class 3
27
Refers to the ability to discover or determine the existence, presence, or fact of a hazard
Detectability
28
Refers to damage to health, including the damage that can occur from loss of product quality or availability
Harm
29
Refers to the potential source of harm
Hazard
30
Refers to all phases in the life of the product from the initial development through marketing until the product's discontinuation
Product lifecycle
31
Refers to the degree to which a set of inherent properties of a product, system, or process fulfills requirements
Quality
32
Refers to the combination of the probability of occurrence of harm and the severity of that harm
Risk
33
A systematic process for the assessment, control, communication, and review of risks to the quality of the drug product across the product lifecycle
Quality risk management
34
The sum of all aspects of a system that implements quality policy and ensures that quality objectives are met
Quality system
35
Assessment that consists of the process of the identification of hazards and the analysis and evaluation of risks associated with exposure to those hazards
Risk assessment
36
Refers to the systematic use of information to identify hazards referring to the risk question or problem description
Risk identification
37
Refers to the estimation of the risk associated with the identified hazard
Risk analysis
38
An evaluation that compares the identified and analyzed risk against given risk criteria
Risk evaluation
39
Refers to the decision making to reduce and/or to accept risks
Risk control
40
Reduction that focuses on the process for mitigation or avoidance of quality risk when it exceeds a specified level
Risk reduction
41
Refers to a decision to accept risk; can be a formal or passive decision
Risk acceptance
42
Refers to the sharing of information about risk and risk management between the decision makers and other parties
Risk communication
43
Refers to reviewing outputs/results of the risk management process
Risk review
44
Meaning of FMEA
Failure mode effects analysis
45
Meaning of FMECA
Failure mode, effects, and criticality analysis
46
Meaning of FTA
Fault tree analysis
47
Meaning of HACCP
Hazard analysis and critical control points
48
Meaning of HAZOP
Hazard operability analysis
49
Meaning of PHA
Preliminary hazard analysis
50
Refers to a systematic analysis of potential failure modes aimed at preventing failures
Failure mode and effect analysis
51
A number that is simply calculated by multiplying the severity rating, times the occurrence probability rating, times the detection probability rating of all the items
Risk priority number (RPN)
52
Refers to the ability of a drug to retain its chemical, physical, microbiological, and biopharmaceutical properties within specified limits throughout its shelf-life
Stability
53
The period of time during which a drug product is expected, if stored correctly, to remain within specification as determined by stability studies on a number of batches of the product
Shelf life/Expiration dating period/Validity period
54
Refers to a series of tests designed to obtain information on the stability of a pharmaceutical product
Stability tests
55
Refers to the date indicating the completion date of the manufacture of a batch
Date of manufacture
56
Refers to the date placed on the container of a drug product that designates the date up to and including which the product is expected to remain within specification if stored correctly
Expiration date
57
Refers to the period of time for which the API remains within specification when stored under the recommended conditions in the proposed bulk storage container
Re-test period
58
Refers to the shelf-life determined by projecting results from accelerated stability studies
Provisional shelf-life
59
Refers to the period of time during which a reconstituted preparation or the finished dosage form in an opened multidose container can be used
Utilization period
60
Type of testing that establishes the "period of time during which a multidose product can be used while retaining quality within an accepted specification once the container is opened"
In-use stability testing
61
Refers to conditions that involve storage in dry, well-ventilated premises at temperatures of 15-25°C, or depending on climatic conditions, up to 30°C
Normal storage conditions
62
Type of testing designed to increase the rate of chemical degradation and physical change of a drug by using exaggerated storage conditions
Accelerated stability testing
63
Studies on the physical, chemical, biological, biopharmaceutical, and microbiological characteristics of a drug, during and beyond the expected shelf-life
Shelf-life stability studies
64
Refers to a list of tests, references to analytical procedures, and appropriate acceptance criteria which are numerical in limits, ranges, or other criteria for the tests described
Specifications
65
Refers to the specifications that determine the suitability of a drug substance throughout its retest period
Re-test specifications
66
Refers to the specifications that determine the suitability of a drug product at the time of its release
Release specifications
67
Stability tests are performed to provide a means of comparing alternative formulations (Phases of development)
Product development phase
68
The drug regulatory authority will require the manufacturer to submit information on the stability of the product (Phases of development)
Registration phase
69
The manufacturer carries out on-going real-time stability studies to substantiate the expiry date and the storage conditions previously projected (Phases of development)
Post-registration phase
70
Each active ingredient retains its chemical integrity and labeled potency within the specified limits (Type of stability)
Chemical stability
71
The original physical properties, including appearance, palatability, uniformity, dissolution, and suspendability, are retained (Type of stability)
Physical stability
72
Sterility or resistance to microbial growth is retained according to the specified requirements (Type of stability)
Microbiological stability
73
The therapeutic effect remains unchanged (Type of stability)
Therapeutic stability
74
No significant increase in toxicity occurs (Type of stability)
Toxicological stability
75
Temperate (International climactic zone)
Zone I
76
Subtropical, with possible high humidity (International climactic zone)
Zone II
77
Hot/dry (International climactic zone)
Zone III
78
Hot/humid (International climactic zone)
Zone IV
79
ASEAN nations & Brazil have adopted __________°C & __________% RH
30°C & 75% RH
80
A design in which only the extremes are tested at all time points (Types of reduced study designs)
Bracketing
81
A design in which a selected subset of samples is tested (Types of reduced study designs)
Matrixing
82
Refers to the lowest amount of analyte in a sample which can be quantitatively determined with suitable precision and accuracy
Quantitation limit